Calendar of Events
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
S Sun
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
2 events,
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Douglas DiRuggiero, PA-C
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Douglas DiRuggiero, PA-C
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Ben Ehst, MD
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Ben Ehst, MD
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
2 events,
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Meagen McCusker, MD
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Meagen McCusker, MD
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in driving this activity; and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Eingun Song, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Eingun Song, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
2 events,
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Cory Rubin, MD
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Cory Rubin, MD
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Jason Hawkes, MD
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Jason Hawkes, MD
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
2 events,
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Matt Bruno, PA-C
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Matt Bruno, PA-C
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in driving this activity; and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Alexandra Golant, MD
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Alexandra Golant, MD
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.